Schwab Charles CORP Form 4 insider transactions

Peter J. Morgan III, General Counsel of Charles Schwab Corp., sold 10,176 shares of common stock for approximately $87.39 per share on May 22, 2025, as part of a Rule 10b5-1 plan.

Jonathan M. Craig, MD, Head of Investor Services at Charles Schwab Corp, exercised stock options and sold the resulting shares on May 21, 2025.

Charles Ruffel, a director at Charles Schwab Corp, recently sold 5,556 shares of common stock at an average price of $87.6505.

Walter Bettinger, Co-Chairman of Schwab, reports a sale of common stock and updates to his beneficial ownership, including holdings through ESPP, ESOP, and spousal ownership.

Director Carolyn Schwab-Pomerantz sold shares of Charles Schwab Corp (SCHW) in multiple transactions on May 16, 2025.

Charles Schwab, Co-Chairman of Charles Schwab Corp, sold 120,000 shares of SCHW stock at an average price of $85.3937 on May 12, 2025.

Richard Wurster, President & CEO of Charles Schwab Corp, sold 15,345 shares of common stock at an average price of $84.0787 on May 9, 2025.

Charles Schwab, Co-Chairman of Charles Schwab Corp, reported the disposal of common stock through indirect ownership via trust, limited partnership, 188 Corp, and as trustee for spouse.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, exercised stock options and sold shares on May 8, 2025, according to a Form 4 filing.

Jonathan Beatty, MD, Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares according to a pre-arranged trading plan.

Nigel Murtagh, Chief Risk Officer of Charles Schwab Corp, exercised stock options and sold 25,000 shares of common stock at $85 per share on May 8, 2025, according to a Form 4 filing.

Nigel Murtagh, Chief Risk Officer of Schwab, reports changes in beneficial ownership of company stock, including shares acquired through dividend reinvestment and an employee stock purchase plan.

Richard Wurster, President & CEO of Charles Schwab Corp, reports disposition of common stock and holdings in employee stock purchase plan.

Charles Schwab, Co-Chairman of the Charles Schwab Corporation, reported the disposal of common stock held indirectly through a trust.

Paul Woolway, MD and Chief Banking Officer of Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold shares of common stock on May 1, 2025, under a pre-arranged 10b5-1 trading plan.

Jonathan M. Craig, MD, Head of Investor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Charles Schwab reports a transaction involving common stock, resulting in adjustments to his beneficial ownership.

Charles R. Schwab, Co-Chairman of Charles Schwab Corp, sold 37,585 shares of common stock at an average price of $79.5477 on April 28, 2025.

Director Carolyn Schwab-Pomerantz exercised stock options and sold shares of Charles Schwab Corp on April 22, 2025.

Director Frank Herringer reports exercising stock options and selling shares of Charles Schwab Corp.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on April 3, 2025, under a pre-arranged 10b5-1 trading plan.

Director Marianne Catherine Brown acquired 483 Restricted Stock Units (RSUs) in Schwab Charles Corp on April 1, 2025, as part of the Directors' Deferred Compensation Plan II.

Director Stephen A. Ellis acquired 435 Restricted Stock Units (RSUs) of Charles Schwab Corp on April 1, 2025, under the Directors' Deferred Compensation Plan II.

Director Frank Herringer acquired stock options and restricted stock units in The Charles Schwab Corporation in lieu of cash compensation.

Charles A. Ruffel, a director of Charles Schwab Corp, acquired 1,567 nonqualified stock options on April 1, 2025, under the Directors' Deferred Compensation Plan II.

Paul Woolway, MD, Chief Banking Officer of Schwab, sold shares of common stock on April 1, 2025, under a pre-arranged 10b5-1 trading plan.

Todd M Ricketts, a director at Charles Schwab Corp, reported a transaction involving common stock on March 31, 2025.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Charles Ruffel, a director at Charles Schwab Corp, exercised stock options and acquired shares on March 14, 2025.